Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | MGAM | O43451 | 2/20 | 0.34 |
| ▸ | SI | P14410 | 2/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337596 | 0.91 | TSHR (0.48) | TSHRPPARDPOLBCA12CA1 | |
| SCHEMBL28862969 | 0.89 | TSHR (0.46) | TSHRPPARDPOLBCA12CA1 | |
| SCHEMBL2238293 | 0.86 | TSHR (0.43) | TSHRPPARDHSD17B10ALDH1A1GAA | |
| SCHEMBL991 | 0.84 | TSHR (0.46) | TSHRPOLBCA12HSD17B10ALDH1A1 | |
| SCHEMBL2242177 | 0.84 | POLB (0.37) | TSHRPOLBCA12CA1CA2 | |
| SCHEMBL9424637 | 0.82 | POLB (0.44) | TSHRPOLBCA12HSD17B10ALDH1A1 | |
| SCHEMBL2240359 | 0.81 | CYP3A4 (0.45) | TSHRPOLBCA1CA2ALDH1A1 | |
| SCHEMBL22662253 | 0.79 | TSHR (0.44) | TSHRPPARDCA12CA1CA2 | |
| SCHEMBL8161275 | 0.79 | TSHR (0.44) | TSHRPPARDCA12CA1CA2 | |
| SCHEMBL15439350 | 0.79 | TSHR (0.45) | TSHRPPARDPOLBCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116987034-A | 5- ((4-chloro-2, 3-dihydro-1H-inden-1-yl) methyl) -1H-imidazole and synthetic method thereof | 安徽大学 | 2023-11-03 | — | — | CN | claimed |
| WO-2010084507-A2 | PROCESS FOR THE PREPARATION OF N-METHYL-2-[3-(1-METHYL-4-PIPERIDYL)-1H-INDOL-5-YL]-ETHANESULFONAMIDE AND ITS ACID ADDITION SALTS | SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) | 2010-07-29 | — | — | WO | claimed |
| US-20240128511-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-04-18 | — | — | US | disclosed |
| US-11942601-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-03-26 | — | — | US | disclosed |
| CN-116987034-A | 5- ((4-chloro-2, 3-dihydro-1H-inden-1-yl) methyl) -1H-imidazole and synthetic method thereof | 安徽大学 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023125373-A1 | METHOD FOR PREPARING RUXOLITINIB AND INTERMEDIATE THEREOF | 江苏威凯尔医药科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| US-20220336858-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITUSBISHI CHEMICAL CORPORATION (JP) | 2022-10-20 | — | — | US | disclosed |
| US-11424482-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-08-23 | — | — | US | disclosed |
| CN-105449189-B | Lithium secondary battery | 麦克赛尔控股株式会社 | 2020-12-01 | — | — | CN | disclosed |
| CN-105576279-B | Lithium secondary battery | 麦克赛尔控股株式会社 | 2020-05-12 | — | — | CN | disclosed |
| US-20190334208-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-10-31 | — | — | US | disclosed |
| EP-0711773-B1 | HYMENIALDISINE AND DERIVATIVE THEREOF, PROCESS FOR PRODUCING INTERMEDIATE FOR SYNTHESIZING THE SAME, AND SAID INTERMEDIATE | SUNTORY LTD (JP) | 2001-09-12 | — | — | EP | disclosed |
| EP-0889877-B1 | META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS | SEARLE & CO (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-1029382-A1 | COMPOSITE SUITABLE FOR USE IN ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-23 | — | — | EP | disclosed |
| WO-1999019917-A2 | COMPOSITE SUITABLE FOR USE IN ELECTROCHEMICAL CELLS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-22 | — | — | WO | disclosed |
| EP-0889877-A1 | META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS | G.D. SEARLE & CO. (US) | 1999-01-13 | — | — | EP | disclosed |
| WO-1997036862-A1 | META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS | G.D. SEARLE & CO. (US) | 1997-10-09 | — | — | WO | disclosed |
| US-5621099-A | CARDIOVASCULAR DISORDERS | SUNTORY LIMITED (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0711773-A1 | HYMENIALDISINE AND DERIVATIVE THEREOF, PROCESS FOR PRODUCING INTERMEDIATE FOR SYNTHESIZING THE SAME, AND SAID INTERMEDIATE | SUNTORY LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
| US-5025002-A | Broad spectrum biocide, industrial process systems | BROMINE COMPOUNDS LTD. (IL) | 1991-06-18 | — | — | US | disclosed |